Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 1490-1493, May 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogel, F. S.
Right arrow Articles by Jeffs, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, F. S.
Right arrow Articles by Jeffs, P. W.

Intracellular Activation of {gamma}-L-Glutaminyl-4-hydroxybenzene by Tyrosinase, a Mechanism for Selective Cytotoxicity against Melanocarcinoma1

F. Stephen Vogel, Lieselotte A. K. Kemper, Kim Boekelheide, Doyle G. Graham and Peter W. Jeffs

Department of Pathology Duke University Medical Center [F. S. V., L. A. K. K., K. B., D. G. G.] and Department of Chemistry Duke University [P. W. J.] Durham, North Carolina 27710

In the presence of tyrosinase, the phenol {gamma}-L-glutaminyl-4-hydroxybenzene is oxidized to a quinone that strongly inhibits metabolism of neoplastic cells in vitro. Conceptually, this enzymatic dependency could initiate specific cytotoxicity in vivo directed to cells that contain tyrosinase. In tests of this hypothesis, the injection of {gamma}-L-glutaminyl-4-hydroxybenzene with probenecid significantly inhibited the growth of human melanoma in athymic mice without apparent toxicity to the cells of the host that lack the enzyme.

1 This investigation was supported in part by Grant CA 19013 awarded by the National Cancer Institute.

Received 10/ 3/78. Accepted 1/26/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.